Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN)

Historical Holders from Q4 2020 to Q1 2025

Symbol
ELDN on Nasdaq
CUSIP
28617K101
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
62.9M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
38.5M
Holdings value
$159M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
75
Number of buys
58
Number of sells
-5
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 4.99% $10.6M 3.14M Armistice Capital, LLC Dec 31, 2024
Frazier Life Sciences Public Fund, L.P. 2% $3.99M 1.18M James N. Topper Dec 31, 2024

Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 41K $139K +$51K $3.39 3
2024 Q4 38.5M $159M +$82M $4.12 75
2024 Q3 18.5M $46M +$411K $2.49 33
2024 Q2 18.3M $48.2M +$22.9M $2.64 31
2024 Q1 9.6M $19.8M +$915K $2.06 28
2023 Q4 9.15M $16.5M +$507K $1.80 28
2023 Q3 8.92M $12.2M -$169K $1.37 28
2023 Q2 9.28M $12.7M +$2.93M $1.37 32
2023 Q1 6.24M $14.7M -$15.1K $2.36 29
2022 Q4 6.25M $14.4M -$296K $2.28 26
2022 Q3 6.27M $17.3M -$726K $2.76 26
2022 Q2 6.53M $15.9M -$1.24M $2.44 28
2022 Q1 7M $27.6M -$4.35M $3.94 31
2021 Q4 7.88M $34.7M -$3.53M $4.41 35
2021 Q3 8.43M $52.1M -$6.53M $6.18 32
2021 Q2 9.42M $74.5M +$5.45M $7.91 30
2021 Q1 8.32M $89M +$88.6M $10.70 32
2020 Q4 36.1K $556K +$556K $15.40 1